These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 3358633

  • 21. Cytotoxic effects of glutathione synthesis inhibition by L-buthionine-(SR)-sulfoximine on human and murine tumor cells.
    Dorr RT, Liddil JD, Soble MJ.
    Invest New Drugs; 1986; 4(4):305-13. PubMed ID: 3583642
    [Abstract] [Full Text] [Related]

  • 22. Enhancement of arsenic trioxide-induced apoptosis in renal cell carcinoma cells by L-buthionine sulfoximine.
    Wu XX, Ogawa O, Kakehi Y.
    Int J Oncol; 2004 Jun; 24(6):1489-97. PubMed ID: 15138592
    [Abstract] [Full Text] [Related]

  • 23. Effect of doxorubicin on glutathione and glutathione-dependent enzymes in cultured rat heart cells.
    Paranka NS, Dorr RT.
    Anticancer Res; 1994 Jun; 14(5A):2047-52. PubMed ID: 7847848
    [Abstract] [Full Text] [Related]

  • 24. Glutathione depletion by DL-buthionine-SR-sulfoximine (BSO) potentiates X-ray-induced chromosome lesions after liquid holding recovery.
    Bertsche U, Schorn H.
    Radiat Res; 1986 Mar; 105(3):351-69. PubMed ID: 3754339
    [Abstract] [Full Text] [Related]

  • 25. Enhancement of murine phenytoin teratogenicity by the gamma-glutamylcysteine synthetase inhibitor L-buthionine-(S,R)-sulfoximine and by the glutathione depletor diethyl maleate.
    Wong M, Helston LM, Wells PG.
    Teratology; 1989 Aug; 40(2):127-41. PubMed ID: 2772848
    [Abstract] [Full Text] [Related]

  • 26. Effects of glutathione depletion by buthionine sulfoximine on radiosensitization by oxygen and misonidazole in vitro.
    Shrieve DC, Denekamp J, Minchinton AI.
    Radiat Res; 1985 Jun; 102(3):283-94. PubMed ID: 4070545
    [Abstract] [Full Text] [Related]

  • 27. Influence of buthionine sulfoximine and misonidazole on glutathione level and radiosensitivity of human tumor xenografts.
    Guichard M, Lespinasse F, Malaise EP.
    Radiat Res; 1986 Jan; 105(1):115-25. PubMed ID: 3945723
    [Abstract] [Full Text] [Related]

  • 28. Effects of L-phenylalanine mustard and L-buthionine sulfoximine on murine and human hematopoietic progenitor cells in vitro.
    Du DL, Volpe DA, Grieshaber CK, Murphy MJ.
    Cancer Res; 1990 Jul 01; 50(13):4038-43. PubMed ID: 2354454
    [Abstract] [Full Text] [Related]

  • 29. Variable baseline gamma-glutamylcysteine synthetase messenger RNA expression in peripheral mononuclear cells of cancer patients, and its induction by buthionine sulfoximine treatment.
    Yao K, Godwin AK, Ozols RF, Hamilton TC, O'Dwyer PJ.
    Cancer Res; 1993 Aug 15; 53(16):3662-6. PubMed ID: 8101766
    [Abstract] [Full Text] [Related]

  • 30. Melanin content and downregulation of glutathione S-transferase contribute to the action of L-buthionine-S-sulfoximine on human melanoma.
    Fruehauf JP, Zonis S, al-Bassam M, Kyshtoobayeva A, Dasgupta C, Milovanovic T, Parker RJ, Buzaid AC.
    Chem Biol Interact; 1998 Apr 24; 111-112():277-305. PubMed ID: 9679561
    [Abstract] [Full Text] [Related]

  • 31. Glutathione depletion by L-buthionine sulfoximine antagonizes taxol cytotoxicity.
    Liebmann JE, Hahn SM, Cook JA, Lipschultz C, Mitchell JB, Kaufman DC.
    Cancer Res; 1993 May 01; 53(9):2066-70. PubMed ID: 8097674
    [Abstract] [Full Text] [Related]

  • 32. SR-2508 plus buthionine sulfoximine or SR-2508 alone: effects on the radiation response and the glutathione content of a human tumor xenograft.
    Lespinasse F, Biscay P, Malaise EP, Guichard M.
    Radiat Res; 1987 Apr 01; 110(1):149-54. PubMed ID: 2951766
    [Abstract] [Full Text] [Related]

  • 33. L-Buthionine (S,R) sulfoximine depletes hepatic glutathione but protects against ethanol-induced liver injury.
    Donohue TM, Curry-McCoy TV, Todero SL, White RL, Kharbanda KK, Nanji AA, Osna NA.
    Alcohol Clin Exp Res; 2007 Jun 01; 31(6):1053-60. PubMed ID: 17428293
    [Abstract] [Full Text] [Related]

  • 34. Potentiation of the cytostatic effect of melphalan on colorectal cancer hepatic metastases by infusion of buthionine sulfoximine (BSO) in the rat: enhanced tumor glutathione depletion by infusion of BSO in the hepatic artery.
    Vahrmeijer AL, van Dierendonck JH, Schutrups J, van de Velde CJ, Mulder GJ.
    Cancer Chemother Pharmacol; 1999 Jun 01; 44(2):111-6. PubMed ID: 10412944
    [Abstract] [Full Text] [Related]

  • 35. Rate of buthionine sulfoximine entry into brain and xenotransplanted human gliomas.
    Fekete I, Griffith OW, Schlageter KE, Bigner DD, Friedman HS, Groothuis DR.
    Cancer Res; 1990 Feb 15; 50(4):1251-6. PubMed ID: 2297773
    [Abstract] [Full Text] [Related]

  • 36. Establishment of a melphalan-resistant rhabdomyosarcoma xenograft with cross-resistance to vincristine and enhanced sensitivity following buthionine sulfoximine-mediated glutathione depletion.
    Rosenberg MC, Colvin OM, Griffith OW, Bigner SH, Elion GB, Horton JK, Lilley E, Bigner DD, Friedman HS.
    Cancer Res; 1989 Dec 15; 49(24 Pt 1):6917-22. PubMed ID: 2582434
    [Abstract] [Full Text] [Related]

  • 37. Development of resistance to MOPC-315 plasmacytoma after intralesional and intraperitoneal melphalan therapy of tumor-bearing BALB/c mice. I. Enhancement of in vivo rejection responses by combined chemotherapy-immunotherapy.
    Adler A, Altbaum I.
    J Natl Cancer Inst; 1982 Jun 15; 68(6):963-9. PubMed ID: 6953275
    [Abstract] [Full Text] [Related]

  • 38. Chemotherapy with [SP-4-3-(R)]-[1,1-cyclobutanedicarboxylato(2-)](2- methyl-1,4-butanediamine-N,N')platinum (CI-973, NK121) in combination with standard agents against murine tumors in vivo.
    Elliott WL, Roberts BJ, Howard CT, Leopold WR.
    Cancer Res; 1994 Aug 15; 54(16):4412-8. PubMed ID: 8044790
    [Abstract] [Full Text] [Related]

  • 39. Glutathione as a determinant of cellular response to doxorubicin.
    Lee FY, Vessey AR, Siemann DW.
    NCI Monogr; 1988 Aug 15; (6):211-5. PubMed ID: 3352767
    [Abstract] [Full Text] [Related]

  • 40. Effect of glutathione depletion by buthionine sulfoximine on doxorubicin toxicity in mice.
    Kisara S, Furusawa S, Takayanagi Y, Sasaki K.
    Res Commun Mol Pathol Pharmacol; 1995 Sep 15; 89(3):401-10. PubMed ID: 8680808
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.